Background: The corona virus disease 2019 (COVID-19) epidemic in China was caused by the extreme acute respiratory syndrome corona virus 2 (SARSCoV-2), December 2019. The clinical manifestations and management of COVID-19 patients remain largely unexplored. However, successful detection is necessary for the diagnosis of SARS-CoV-2 infection. For SARS-CoV-2-infected patients, aiming at evaluating antibodies-based and nucleic acid-based test results.